Hong Kong ChaoShang Group Limited (SEHK:2322) entered into a memorandum of understanding to acquire Shenzhen City Lianhao Health and Chronic Disease Management Co. Ltd from Zheng Jinqiang and Huang Minfen on May 5, 2023. The Company may conduct due diligence including business, financial and legal due diligence on the Target Group for six months from the date of the memorandum of understanding.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.62 HKD | -1.59% | +1.64% | -33.33% |
05-06 | Hong Kong Chaoshang Ends MoU for Acquisition of Medical Equipment, Drug Marketing Company | MT |
02-02 | Hong Kong ChaoShang Disposes Of Remaining Shares in Royal Century Resources | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.33% | 327M | |
+12.94% | 109B | |
+0.91% | 30.23B | |
+12.31% | 22.34B | |
-11.83% | 18.66B | |
-8.62% | 16.99B | |
+15.54% | 16.24B | |
-5.91% | 12.07B | |
+1.93% | 10.99B | |
-15.91% | 8.36B |
- Stock Market
- Equities
- 2322 Stock
- News Hong Kong ChaoShang Group Limited
- Hong Kong ChaoShang Group Limited entered into a memorandum of understanding to acquire Shenzhen City Lianhao Health and Chronic Disease Management Co. Ltd from Zheng Jinqiang and Huang Minfen